Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-05 Option Award | 2022-07-07 4:27 pm | N/A 2032-07-05 | MEI Pharma Inc. | MEIP | Glover Nicholas Director | 87,500 | $0 | 367,500 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-06 6:59 pm | N/A 2031-07-01 | MEI Pharma Inc. | MEIP | Glover Nicholas Director | 50,000 | $0 | 280,000 (Direct) | View |
| 2020-07-02 Option Award | 2020-07-07 1:30 pm | N/A 2030-07-02 | MEI Pharma Inc. | MEIP | Glover Nicholas Director | 50,000 | $0 | 230,000 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-27 4:14 pm | N/A 2030-02-25 | Sierra Oncology Inc. | SRRA | Glover Nicholas CEO and President | 359,158 | $0 | 359,158 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-03 3:32 pm | N/A 2029-07-01 | MEI Pharma Inc. | MEIP | Glover Nicholas Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-03-04 Option Award | 2019-03-05 5:26 pm | N/A 2029-03-04 | Sierra Oncology Inc. | SRRA | Glover Nicholas CEO and President | 607,500 | $0 | 607,500 (Direct) | View |